Metabolic syndrome may increase operative mortality in patients undergoing coronary artery bypass graft surgery

摘要

Evaluation of: Echahidi N, Pibarot P, Despres JP et al.: Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J. Am. Coll. Cardiol. 50(8), 843–851 (2007). Metabolic syndrome (MS) is associated with increased risk of coronary heart disease, stroke and cardiovascular mortality. However, little data exist on the relationship between MS and operative mortality following coronary revascularization. This retrospective study found that MS in patients undergoing coronary artery bypass graft (CABG) surgery is a significant independent predictor of an increased risk of post-operative mortality. Thus, MS may be an important and novel patient risk factor for CABG surgery.